Login / Signup

Imaging as a surrogate marker of drug efficacy in cardiovascular disease.

Jason M TarkinMarc R DweckJames H F Rudd
Published in: Heart (British Cardiac Society) (2018)
Keyphrases
  • cardiovascular disease
  • high resolution
  • type diabetes
  • adverse drug
  • cardiovascular events
  • metabolic syndrome
  • fluorescence imaging
  • coronary artery disease